Cargando...
Adherence to and persistence with zoledronic acid treatment for osteoporosis—reasons for early discontinuation
SUMMARY: This retrospective study reports 81% long-term (> 3 years) adherence to and 77% persistence with zoledronic acid (ZA) treatment in osteoporosis patients, with ZA being costfree for patients. Eight percent of patients discontinued treatment because of adverse events (AEs), with a tendency...
Gardado en:
| Publicado en: | Arch Osteoporos |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Springer London
2020
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7165128/ https://ncbi.nlm.nih.gov/pubmed/32303862 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11657-020-00733-4 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|